Cargando…
A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A
Hemophilia-A (HA) is caused by heterogeneous loss-of-function factor (F)VIII gene (F8)-mutations and deficiencies in plasma-FVIII-activity that impair intrinsic-pathway-mediated coagulation-amplification. The standard-of-care for severe-HA-patients is regular infusions of therapeutic-FVIII-proteins...
Autores principales: | Howard, Tom, Almieda, Marcio, Diego, Vincent, Viel, Kevin, Luu, Bernadette, Haack, Karin, Raja, Rajalingam, Ameri, Afshin, Chitlur, Meera, Rydz, Natalia, Lillicrap, David, Watts, Raymond, Kessler, Craig, Ramsey, Christopher, Dinh, Long, Kim, Benjamin, Powell, Jerry, Peralta, Juan, Bouls, Ruayda, Abraham, Shirley, Shen, Yu-Min, Murillo, Carlos, Mead, Henry, Lehmann, Paul, Fine, Eli, Escobar, Miguel, Kumar, Satish, Williams-Blangero, Sarah, Kasper, Carol, Almasy, Laura, Cole, Shelley, Blangero, John, Konkle, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602130/ https://www.ncbi.nlm.nih.gov/pubmed/37886476 http://dx.doi.org/10.21203/rs.3.rs-3371095/v1 |
Ejemplares similares
-
Synthesis of FVIII in Hemophilia-A patients with the intron-22-inversion may modulate immunogenicity
por: Pandey, Gouri Shankar, et al.
Publicado: (2013) -
Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice
por: Afraz, Sajjad, et al.
Publicado: (2022) -
Recombinant FVIII: the milestone of modern hemophilia treatment
por: Mannucci, Pier Mannuccio
Publicado: (2023) -
Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
por: Nguyen, S., et al.
Publicado: (2019) -
Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation
por: Swystun, Laura L, et al.
Publicado: (2023)